Join Matt Pillar and Erin Harris as we catch up with Celyad Oncology chief Filippo Petti on his company's  differentiated approach to the discovery and development of allogeneic CAR-T cell therapy candidates for the treatment of cancer. Petti shares the technology and how the company intends to scale in-house manufacturing in its Belgium-based manufacturing facility.